Key result
Hybrid robotic AVR plus PCI shows safety and feasibility for concomitant AS and CAD.
Why the study?
Robotic-assisted aortic valve replacement has emerged as a novel minimally invasive approach to surgically manage aortic valve disease.
Is a hybrid approach of robotic-assisted aortic valve replacement and percutaneous coronary intervention safe and feasible in a patient with concomitant severe aortic stenosis and coronary artery disease?
Case Report (n=1)
Is a hybrid approach of robotic-assisted aortic valve replacement and percutaneous coronary intervention safe and feasible in a patient with concomitant severe aortic stenosis and coronary artery disease?
A hybrid approach combining robotic-assisted aortic valve replacement with a sutureless prosthesis and PCI is a feasible, minimally invasive option for patients with concomitant severe aortic stenosis and coronary artery disease.
Hypothesis-generating for hybrid RAVR-PCI in select patients; prospective trials needed before clinical adoption.
BACKGROUND: Robotic-assisted aortic valve replacement (RAVR) has emerged as a novel minimally invasive approach to surgically manage aortic valve disease. CASE SUMMARY: A 74-year-old man presented with several months of worsening dyspnea and chest pain on exertion. Preoperative work-up identified severe aortic stenosis along with coronary artery disease. Despite being at low operative risk, the patient had a small aortic root, coronary disease not amenable to surgical revascularization, and wanted to avoid sternotomy. The decision was made to perform RAVR with percutaneous coronary intervention in a hybrid approach to manage his concomitant pathologies. DISCUSSION: We demonstrate the safety and feasibility of performing RAVR using a sutureless aortic valve prosthesis to optimize hemodynamics in a patient with a small aortic root. We also describe the combination of RAVR and percutaneous coronary intervention as part of a hybrid treatment paradigm to manage concomitant aortic stenosis and coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Toubat et al. (2026) conducted a case report in Severe aortic stenosis and coronary artery disease (n=1). Robotic-assisted aortic valve replacement (RAVR) with percutaneous coronary intervention (PCI) was evaluated on Safety and feasibility. Robotic-assisted aortic valve replacement combined with percutaneous coronary intervention was demonstrated to be a safe and feasible hybrid approach for managing concomitant aortic stenosis and CAD.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: